Healthcare Wrap: Commercial Winners Rally as Post-Halt Names Lose Steam

• Opthea sank 97.50% as investors digested its reset around a narrower rare lung disease plan.
• Control Bionics jumped 41.07% after new reimbursement and distribution wins in the US and Europe.
• Biome Australia climbed 26.88% on plans to move probiotic production onshore and lift gross margin.
• Capital raisings stayed heavy, with EBR Systems, Pacific Edge and Paradigm all securing fresh funds.